Annual report
9818.TEDINET S100OKOF
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥21.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥18.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.6bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥988m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥991m | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥946m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥904m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥867m | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥755m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥671m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥848m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥598m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥478m | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥755m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥671m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥20.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥19.4bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥19.4bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.2bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥14.5bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.9bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.8bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥12.0bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥11.3bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥10.8bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.8bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.8bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.1bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.3bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.6bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥531m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥445m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥228m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥269m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥99.14 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.06 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥111.29 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.45 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.25 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,754.24 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,663.56 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,572.8 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,478.15 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,411.61 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 66.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.2% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.0% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.4% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.8% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 545 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 510 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 497 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 408 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 396 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥21.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥17.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥16.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥15.8bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥942m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥1.0bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥947m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥867m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥816m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.1bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.0bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥750m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥681m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥887m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥585m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥450m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥18.2bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥17.3bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥16.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.9bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.2bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.9bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥4.7bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥13.3bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥12.6bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.9bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥11.2bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥10.7bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.2bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥98.37 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.41 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.47 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.74 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.56 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥21 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20.5 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,745.23 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,659.1 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,566.95 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,467.12 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,402.29 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 73.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.4% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 5.8% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.3% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,046,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 407 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 388 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 373 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 365 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 354 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥6.4bn |
| Aquareportable segment | capex | 2021-04-01 → 2022-03-31 | ¥129m |
| Aquareportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥53m |
| Aquareportable segment | employees | at 2022-03-31 | 89 pure |
| Aquareportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Aquareportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Aquareportable segment | segment assets | at 2022-03-31 | ¥2.6bn |
| Aquareportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥31m |
| Livingreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Livingreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥517m |
| Livingreportable segment | employees | at 2022-03-31 | 256 pure |
| Livingreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥18.3bn |
| Livingreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥18.3bn |
| Livingreportable segment | segment assets | at 2022-03-31 | ¥6.6bn |
| Livingreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥626m |
| Medical And Industrial Gasreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥866m |
| Medical And Industrial Gasreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥305m |
| Medical And Industrial Gasreportable segment | employees | at 2022-03-31 | 200 pure |
| Medical And Industrial Gasreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥7.0bn |
| Medical And Industrial Gasreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥7.0bn |
| Medical And Industrial Gasreportable segment | segment assets | at 2022-03-31 | ¥4.7bn |
| Medical And Industrial Gasreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥332m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥875m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥26.5bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥26.5bn |
| —segment total | segment assets | at 2022-03-31 | ¥13.9bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥988m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥7.3bn |
| Aquareportable segment | capex | 2020-04-01 → 2021-03-31 | ¥101m |
| Aquareportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥59m |
| Aquareportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.3bn |
| Aquareportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.3bn |
| Aquareportable segment | segment assets | at 2021-03-31 | ¥2.2bn |
| Aquareportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥33m |
| Livingreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥633m |
| Livingreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥498m |
| Livingreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥13.8bn |
| Livingreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥13.8bn |
| Livingreportable segment | segment assets | at 2021-03-31 | ¥5.6bn |
| Livingreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥834m |
| Medical And Industrial Gasreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥606m |
| Medical And Industrial Gasreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥259m |
| Medical And Industrial Gasreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥6.4bn |
| Medical And Industrial Gasreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥6.4bn |
| Medical And Industrial Gasreportable segment | segment assets | at 2021-03-31 | ¥4.3bn |
| Medical And Industrial Gasreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥124m |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥1.3bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥815m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥21.4bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥21.4bn |
| —segment total | segment assets | at 2021-03-31 | ¥12.1bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥991m |
| Aquareportable segment | employees | at 2022-03-31 | 89 pure |
| Livingreportable segment | employees | at 2022-03-31 | 214 pure |
| Medical And Industrial Gasreportable segment | employees | at 2022-03-31 | 104 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,658
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 426800 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0530 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 426800 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 426800 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0530 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 76196000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 10.0 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 83816000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 11.0 | |
| Number of male directors and other officers | FilingDateInstant | 9 | |
| Number of female directors and other officers | FilingDateInstant | 1 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000FurunoAkiraMember | 41000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000IuchiKiyokazuMember | 12000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000AokiAtsuhitoMember | 16000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MiyamaeMasahikoMember | 12000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000TsukamotoTeruhisaMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000NakanoMasashiMember | 14000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000OgawaMitsuguMember | 9000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000NakaiJyoujiMember | 11000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsuiDaisukeMember | 7000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsumotoHiromiMember | 0 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 128000 | |
| Audit fees reporting company | Prior1YearDuration | 24000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | 2000000 | JPY |
| Audit fees reporting company | CurrentYearDuration | 24000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | 1500000 | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 24000000 | JPY |
| Non audit fees total | Prior1YearDuration | 2000000 | JPY |
| Audit fees total | CurrentYearDuration | 24000000 | JPY |
| Non audit fees total | CurrentYearDuration | 1500000 | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 125452000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 83670000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 19800000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 7 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 13766000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 9540000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 3200000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember | 1 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 7206000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 5760000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 950000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 2 | |
| Number of issues shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 3 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |